Lung Cancer – Causes, Symptoms and Treatments
Whether you are a victim of lung cancer or someone who wants to prevent it from occurring, it is important to learn about the causes, symptoms, and treatments. There are several different types of cancer, including Squamous cell carcinoma, Non-small cell lung cancer, and Thymoma. There are also many risk factors and genetic traits that are associated with these types of cancer.
Genetic susceptibility
Despite recent progress, there is no consensus among researchers on what genes are associated with lung cancer. However, studies of familial aggregation and case-control studies provide indirect evidence that there is a common underlying genetic determinant of lung cancer risk. These studies are used to identify inherited susceptibility factors.
Genetic polymorphisms in CYP genes have been shown to alter the risk of lung cancer. In addition, the IL-1beta polymorphism is associated with the rate of decline in lung function in nonsmokers and smokers.
Lung cancer is the leading cause of cancer death in the United States. Most lung cancer is attributable to cigarette smoking. Genetic polymorphisms in CYP, DNA repair, and other genes have been implicated in modifying the risk of lung cancer.
Two recent meta-analyses have examined genetic factors influencing lung cancer risk. One meta-analysis included 1,018 publications. The studies included were published over the past decade. The studies had sufficient genotype information, cross-sectional or cohort design, and peer-reviewed journal publication.
The main meta-analysis evaluated 246 variants in 138 different genes. The subgroup meta-analyses were conducted in the Caucasian and Asian populations. The subgroup meta-analyses were performed for squamous cell carcinoma, small cell lung cancer, and NSCLC. The allele distributions were compared between controls and subjects with lung cancer. The main meta-analyses found 44 variants with significant associations with lung cancer risk. The subgroup meta-analyses found that 26 variants were associated with lung cancer risk in the Asian population, while five variants were associated with lung cancer risk in both the Caucasian and Asian populations.
The most significant findings from this study were that the first-degree relative of a lung cancer patient had a 1.5- to 4-fold higher risk of developing lung cancer than nonsmokers. The risk estimate is likely to be underestimated.
Non-small cell lung cancer
Approximately 43,000 people are diagnosed with lung cancer each year in the UK. This is a leading cause of cancer deaths in men and women.
Smoking is the primary risk factor for non-small cell lung cancer. However, other factors contribute to the risk of lung cancer, including air pollution and exposure to hazardous substances.
Non-small cell lung cancer can be treated with surgery and chemotherapy. However, these treatments are not a cure for the disease. The treatments vary depending on the type of cancer and the stage of the disease. Besides surgery, patients may participate in clinical trials. These are trials that test new treatments. The trials may involve chemotherapy, targeted therapy, immunotherapy, or radiation therapy.
Chemotherapy involves using drugs to kill cancer cells. The drugs are absorbed through the bloodstream and then targeted to the area where the cancer is growing. Chemotherapy may also be used to kill cancer cells that have spread to other parts of the body.
Immunotherapy may also be used to boost the immune system. This type of therapy works by using an enzyme or a dye to detect cancer cells. Antibodies bind to the antigen, activating the dye. This helps the doctor determine whether or not the cancer cells are alive.
In addition to chemotherapy and surgery, other treatments for non-small cell lung cancer include radiation therapy and targeted drug therapy. These treatments are often used in combination. A combination of chemotherapy and radiation therapy is being studied for non-small cell lung cancer.
Other treatment options for non-small cell lung cancer include targeted drug therapy, radiofrequency ablation, and immunotherapy. These treatments can be effective but they may cause side effects.
Squamous cell carcinoma
Among the types of lung cancer, squamous cell lung cancer is the second most common. It accounts for around 30 percent of all cases of lung cancer. It is often associated with smoking. In fact, it has been shown that smoking is a major risk factor for squamous cell lung cancer.
The outlook for patients with squamous cell lung cancer depends on many factors. In general, early diagnosis and treatment are important for improving chances of survival. Other factors that affect outlook include age and general health.
Several therapies are available for squamous cell lung cancer. These include chemotherapy and radiotherapy. For patients who have advanced lung cancer, specific targeted agents have been found to improve survival.
Squamous cell lung cancer is usually slow-growing. However, it may also spread to nearby tissues or organs. The outlook for patients with metastatic squamous cell lung cancer depends heavily on the patient’s response to treatment. In addition, doctors can detect the presence of tumors by using a CT scan. The tumor’s size helps doctors classify cancer into stages.
There are six stages of squamous cell lung cancer. In addition to surgery, treatment options include chemotherapy, radiation therapy, and immunotherapy. Some of these methods have been proven to improve survival, but they have not yet been FDA approved for squamous cell lung cancer.
Some studies have shown that specific targeted agents improve survival for patients with adenosquamous carcinomas and ALK gene rearrangements. In addition, immunotherapy has shown promising results in non-small cell lung cancer. Currently, only one drug, necitumumab, is approved by the FDA for SqCC.
Other treatment options for squamous cell lung cancer include programmed cell death ligand 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibition. The combination of these agents has been proven to improve survival in patients with NSCLC.
Thymomas
Thymomas are a rare type of mediastinal tumor that is characterized by a slow-growing tumor that forms from epithelial cells. They are usually benign but they can develop into malignant tumors that cause pulmonary metastases. There are several clinical symptoms and signs that can be associated with thymomas.
Thymoma symptoms include coughing, dry cough, dyspnea, and chest pain. Other symptoms may include vocal cord paralysis and fever. In addition, some people with thymoma may have paraneoplastic syndromes.
A patient’s diagnosis may be made by an examination of the lung, including a chest x-ray. The chest x-ray can be used to identify the density of the tumor and determine the amount of fluid that is present in the lung. In addition, pulmonary function tests can be used to assess how well the lungs are functioning. If the patient has the paraneoplastic syndrome, a physical examination may reveal a low red blood cell count or low immunoglobulin levels.
A chest CT scan can also be used to assess the density and the location of the tumor. A PET-CT scan may be performed to assess the amount of 18 F-fluorodeoxyglucose uptakes in the tumor. If the tumor is invasive, magnetic resonance imaging may show an invasion of the superior vena cava and the pulmonary artery.
If a patient is diagnosed with thymoma, the first step is to determine if the tumor is malignant. This can be done by performing a needle biopsy. If the biopsy yields sufficient information, then surgical resection is performed. This may remove the tumor, and some patients may also need additional therapy after surgery.
A multidisciplinary team is required to treat thymomas. This includes physicians, medical oncologists, radiation oncologists, thoracic surgeons, and other specialists. Each patient is reviewed by the team after surgery. The team reevaluates each patient every four months for the first two years.
Thymic carcinoma
THYMIC CARPOSE is a rare thoracic malignancy that occurs in adults and children. It originates in the thymus gland, which is a small gland located in the anterior mediastinum under the breastbone. It produces white blood cells called lymphocytes, which are important in the fight against infection. These cells can also become cancerous. They can spread to other parts of the body, such as the lining of the lungs.
In the United States, thymoma is diagnosed in the fourth decade of life, and the incidence is about 1.5 cases per million people. It is often cured by surgery followed by radiation. However, it can recur after a long time. It is important to follow a person for life, to detect any recurrence of thymic carcinoma.
The thymic gland is a small organ that makes white blood cells, which fight infection. It also controls the central tolerance to self-antigens. In the thymus, these cells become cancerous, which may cause thymic cancer.
In a multicenter study from Europe and Japan, thymomas were treated with a multidisciplinary approach. The treatments included induction chemotherapy, robotic thymectomy, and radiation therapy. In addition, patients received consolidation chemotherapy. Surgical resections were also performed.
Patients were followed for a median of 50.3 months. The five-year overall survival rate was 96% for stage I thymoma and 86% for stage II. Patients who received an operation plus port were significantly more likely to have a five-year overall survival rate of 95%. However, this study did not account for the imbalance between stage II versus stage III tumors.
The ITMIG (International Thymic Malignancy Interest Group) is a group of clinicians and basic scientists formed to study thymic malignancies. The group publishes consensus papers on these diseases, and members can pool their clinical experiences in an international database.
Health Sources:
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/
